Industry Roundup: Puerto Rico Supplements Rule, Lunada-FTC Settlement
This article was originally published in The Tan Sheet
Executive Summary
Economax warned on spiked supplement; ASA rejects acupressure immediate relief claim; CRN cautions on folate/autism study findings; and more news in brief.
You may also be interested in...
Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities
Dubious supplement ad claims that have driven FTC enforcement in the sector for some time likely will continue as three commission seats are filled, says advertising practices official Richard Cleland.
NutraClick 'Free' Offer Curbed: Health And Wellness Industry News Roundup
Organic group updates global business guide; FTC doesn't split hairs on Coorga claim; social media etiquette lesson for UK nutritionals firm; and more news in brief.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.